June 29, 2015
San Mateo-based stealthy startup Mousera recently raised $20 million, according to an SEC filing. This brings the company's total funding to at least $28.8 million. Existing investors include Lux Capital, Founders Fund, Data Collective, AME Cloud Ventures, and Dolby Family Ventures.
The company is developing a tool that helps biomedical investigators accelerate the preclinical drug discovery and...
May 18, 2015
Research firm Tractica predicts that worldwide unit shipments of clinical and non-clinical connected wearable patches will grow to 12.3 million per year by 2020. Last year, annual shipments were just 67,000. The market for such connected patches, Tractica predicts, will hit $3.3 billion per year.
Tractica describes the category as including "patches, tattoos, or small devices that are affixed to...
January 12, 2015
Ingestible sensor company Proteus Digital Health and computer giant Oracle have integrated Proteus's digital health feedback system, which includes an ingestible pill sensor, a wearable patch, and a software system, with Oracle's InForm software for data collection. Clinical trial researchers using Oracle's software will now be able to track patients' medication adherence with Proteus's...
October 29, 2014
Proteus Digital Health, which offers medication adherence and wellness monitoring built around an ingestible sensor pill, has quietly launched a new, consumer-facing offering. Proteus Recovery, which now has a Twitter account, a trademark filing, and a section on Proteus's website, is a biometrics monitoring patch for athletes to help them recover from a workout faster.
"Proteus Recover is the...
October 29, 2014
San Mateo-based startup Mousera raised $8.8 million from undisclosed investors, according to a report from MedCity News. The company cryptically states on its website that it's "accelerating medical advancement by bringing 21st century technology into living systems research".
Although the company hasn't released investor names, former Pfizer CEO and Lux Capital Venture Partner Jeff Kindler was...
August 19, 2014
While Novartis' recent partnership with Google and its longtime relationship with Proteus have indicated that the pharma company has an interest in digital health, a page on the company's website, added this summer, lays out its broad vision and explicit interest in mobile health specifically. The company even has a mobile health strategy lead, Michele Angelaccio, who holds the title of Associate...
August 14, 2014
By the end of the second quarter this year, digital health funding had already surpassed the total funding for 2014, according to a June 2014 report from Rock Health. This growth also shows in the top funded companies for the first half of the year.
While Proteus Digital Health received the largest investment in the first half of 2014 as well as the first half of 2013, last year Proteus raised $...
August 5, 2014
Proteus Digital Health
Proteus Digital Health published a paper on its ingestible sensor that explains the design of the sensor, the safety tests Proteus completed, and the clinical trials Proteus conducted with 412 patients who used the system over 5,656 days.
The Proteus digital medicine platform is a medication management and adherence system that includes unique measurement tools, like...
July 29, 2014
Digital medicine company Proteus Digital Health has raised an additional $52 million from undisclosed investors following a whopping $120 million raise the company announced just last month. That brings Proteus' latest round of funding -- its seventh -- to $172 million. By our count the company's total known funding is now close to $400 million, which makes it one of the most-funded, private...
June 30, 2014
In the first half of 2014, digital health funding reached $2.3 billion, according to a report from accelerator Rock Health. The report included data from 143 digital health companies that have raised over $2 million during the past six months.
Funding in the first two quarters of 2014 surpassed total funding for all of 2013, which was $1.97 billion. Deal growth was driven by early-stage companies...